AR056133A1 - Virus de influenza canina y composiciones relacionadas y metodos de uso - Google Patents
Virus de influenza canina y composiciones relacionadas y metodos de usoInfo
- Publication number
- AR056133A1 AR056133A1 ARP060104532A ARP060104532A AR056133A1 AR 056133 A1 AR056133 A1 AR 056133A1 AR P060104532 A ARP060104532 A AR P060104532A AR P060104532 A ARP060104532 A AR P060104532A AR 056133 A1 AR056133 A1 AR 056133A1
- Authority
- AR
- Argentina
- Prior art keywords
- canine influenza
- seq
- methods
- influenza viruses
- related compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 241000282465 Canis Species 0.000 title abstract 3
- 241000700605 Viruses Species 0.000 title abstract 2
- 206010022000 influenza Diseases 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 2
- 241000712461 unidentified influenza virus Species 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/11—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
- C12N2760/16162—Methods of inactivation or attenuation by genetic engineering
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Se provee un virus de influenza canina aislado de subtipo 113N8. que comprende una HA que tiene SEQ ID Ns 4, o una secuencia de aminoácidos que es más de 99% idéntica a SEQ ID Ns 4, con la condicion de que los aminoácidos en las posiciones (94) y (233) son idénticos a los de SEQ ID Ns4; una composicion que comprende virus atenuado o inactivados; proteínas HA, NM, NP, M1, NS1, PA, PB1 y PB2 aisladas o purificadas, y fragmentos de éstas, y composiciones que las comprenden, o ácidos nucleicos que las codifican, opcionalmente como parte de un vector; y un método para inducir una respuesta inmune ante un virus de influenza canina en un animal, que comprende administrarle al animal una composicion mencionada con anterioridad.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72780805P | 2005-10-18 | 2005-10-18 | |
US11/539,123 US7468187B2 (en) | 2005-10-18 | 2006-10-05 | Canine influenza virus and related compositions and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
AR056133A1 true AR056133A1 (es) | 2007-09-19 |
Family
ID=37906978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060104532A AR056133A1 (es) | 2005-10-18 | 2006-10-17 | Virus de influenza canina y composiciones relacionadas y metodos de uso |
Country Status (15)
Country | Link |
---|---|
US (4) | US7468187B2 (es) |
EP (1) | EP1933866B1 (es) |
JP (1) | JP5042230B2 (es) |
KR (1) | KR101412897B1 (es) |
AR (1) | AR056133A1 (es) |
AT (1) | ATE491468T1 (es) |
AU (1) | AU2006304895B2 (es) |
CA (1) | CA2626452C (es) |
DE (1) | DE602006018970D1 (es) |
HK (1) | HK1112846A1 (es) |
NO (1) | NO342145B1 (es) |
NZ (1) | NZ567017A (es) |
RS (1) | RS53723B1 (es) |
RU (1) | RU2410427C2 (es) |
WO (1) | WO2007048086A2 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
KR101738937B1 (ko) * | 2005-04-21 | 2017-05-23 | 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 애즈 레프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈, 센터스 포 디지즈 컨트롤 앤드 프리벤션 | 개과 동물의 호흡기 질병 조절을 위한 물질 및 방법들 |
CA2621320C (en) * | 2005-10-07 | 2016-05-24 | Pfizer Products Inc. | Vaccines and methods to treat canine influenza |
AU2013205112C1 (en) * | 2005-10-19 | 2015-12-03 | Cornell Research Foundation, Inc. | Influenza viruses able to infect canids, uses thereof |
WO2007047728A2 (en) * | 2005-10-20 | 2007-04-26 | Wyeth | Compositions and methods for the treatment of canine influenza virus disease |
US7682619B2 (en) * | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
US7674469B2 (en) | 2006-10-25 | 2010-03-09 | Internet International B.V. | Feline influenza vaccine and method of use |
CA2826060C (en) * | 2011-02-04 | 2019-06-18 | Zoetis Llc | Immunogenic bordetella bronchiseptica compositions |
CA2826058C (en) | 2011-02-04 | 2017-06-06 | Zoetis Llc | Compositions for canine respiratory disease complex |
WO2012125525A2 (en) | 2011-03-14 | 2012-09-20 | Boehringer Ingelheim Vetmedica, Inc. | Equine rhinitis vaccine |
KR101484588B1 (ko) * | 2012-10-24 | 2015-01-20 | 대한민국 | 개 인플루엔자 vlp 백신의 제조방법 |
US10080792B2 (en) | 2013-09-23 | 2018-09-25 | Engen Bio, Inc. | Influenza vaccine and therapy |
CN104436157A (zh) | 2013-09-23 | 2015-03-25 | 恩金生物有限公司 | 流感疫苗和治疗 |
CA3105880A1 (en) * | 2018-07-10 | 2020-01-16 | Seqirus Pty Ltd | Removal of agglomerates |
JP7340290B2 (ja) * | 2021-05-21 | 2023-09-07 | 大輔 島岡 | 抗エンベロープウイルス中性洗浄剤、消毒剤組成物、及びエンベロープウイルスの不活性化方法 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4009258A (en) * | 1972-09-25 | 1977-02-22 | The Mount Sinai School Of Medicine Of The City University Of New York | Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same |
GB1488800A (en) * | 1973-11-29 | 1977-10-12 | Wellcome Found | Influenza vaccines |
US4140762A (en) * | 1974-01-14 | 1979-02-20 | Sandoz Ltd. | Influenza sub-unit vaccine |
US4029763A (en) * | 1974-08-05 | 1977-06-14 | Mount Sinai School Of Medicine Of The City University Of New York | Influenza vaccine containing purified neuraminidase antigen and method of using the same |
US4318903A (en) * | 1978-07-12 | 1982-03-09 | Smithkline-Rit | Live influenza virus vaccine and the preparation thereof |
US4278662A (en) * | 1979-10-16 | 1981-07-14 | Smith Kline - Rit | Attenuated influenza type A virus vaccine |
US4338296A (en) * | 1979-10-16 | 1982-07-06 | Smithkline-Rit | Influenza virus and process of producing a vaccine therefrom |
GB8300467D0 (en) * | 1983-01-08 | 1983-02-09 | Wellcome Found | Equine influenza |
JPH0688911B2 (ja) * | 1985-06-06 | 1994-11-09 | 国立予防衛生研究所長 | インフルエンザワクチン及びその製造方法 |
GB8703696D0 (en) * | 1987-02-18 | 1987-03-25 | Oxford J S | Influenza vaccine |
US5136019A (en) * | 1989-05-24 | 1992-08-04 | Sri International | Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
US5741493A (en) * | 1991-01-24 | 1998-04-21 | Pasteur Merieux Serums Et Vaccins | Vaccine composition against influenza, with synergic effects, containing influenza virus core as an additive |
DE69223406T2 (de) * | 1991-06-19 | 1998-06-25 | New York Medical College | M-Protein des Influenzavirus als antivirales Mittel |
US5762939A (en) | 1993-09-13 | 1998-06-09 | Mg-Pmc, Llc | Method for producing influenza hemagglutinin multivalent vaccines using baculovirus |
ES2370937T3 (es) * | 1993-09-13 | 2011-12-23 | Protein Sciences Corporation | Un método para producir vacunas antigripales polivalentes a base de hemaglutinina. |
AU1308495A (en) * | 1994-01-11 | 1995-08-01 | Rijksuniversiteit Gent | Influenza vaccine |
US6177082B1 (en) * | 1998-08-13 | 2001-01-23 | The University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
US6482414B1 (en) | 1998-08-13 | 2002-11-19 | The University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
IL127331A0 (en) * | 1998-11-30 | 1999-09-22 | Yeda Res & Dev | Peptide-based vaccine for influenza |
US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
KR101738937B1 (ko) | 2005-04-21 | 2017-05-23 | 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 애즈 레프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈, 센터스 포 디지즈 컨트롤 앤드 프리벤션 | 개과 동물의 호흡기 질병 조절을 위한 물질 및 방법들 |
US7959929B2 (en) * | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US7384642B2 (en) * | 2005-08-25 | 2008-06-10 | Merial Limited | Canine influenza vaccines |
CA2621320C (en) * | 2005-10-07 | 2016-05-24 | Pfizer Products Inc. | Vaccines and methods to treat canine influenza |
-
2006
- 2006-10-05 US US11/539,123 patent/US7468187B2/en active Active
- 2006-10-17 AT AT06827896T patent/ATE491468T1/de not_active IP Right Cessation
- 2006-10-17 WO PCT/US2006/060025 patent/WO2007048086A2/en active Application Filing
- 2006-10-17 DE DE602006018970T patent/DE602006018970D1/de active Active
- 2006-10-17 CA CA2626452A patent/CA2626452C/en active Active
- 2006-10-17 AR ARP060104532A patent/AR056133A1/es not_active Application Discontinuation
- 2006-10-17 AU AU2006304895A patent/AU2006304895B2/en active Active
- 2006-10-17 RU RU2008119438/10A patent/RU2410427C2/ru active
- 2006-10-17 NZ NZ567017A patent/NZ567017A/en unknown
- 2006-10-17 EP EP06827896A patent/EP1933866B1/en active Active
- 2006-10-17 KR KR1020087008658A patent/KR101412897B1/ko active IP Right Grant
- 2006-10-17 JP JP2008536626A patent/JP5042230B2/ja active Active
- 2006-10-17 RS RS20080174A patent/RS53723B1/en unknown
-
2008
- 2008-05-07 NO NO20082149A patent/NO342145B1/no unknown
- 2008-07-17 HK HK08107923.9A patent/HK1112846A1/xx unknown
- 2008-09-15 US US12/210,837 patent/US7842295B2/en not_active Ceased
-
2012
- 2012-11-29 US US13/688,990 patent/USRE44916E1/en active Active
-
2013
- 2013-11-08 US US14/075,618 patent/USRE45564E1/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2007048086A9 (en) | 2007-07-19 |
WO2007048086A3 (en) | 2007-10-04 |
JP5042230B2 (ja) | 2012-10-03 |
KR101412897B1 (ko) | 2014-06-27 |
WO2007048086A2 (en) | 2007-04-26 |
RS20080174A (en) | 2009-07-15 |
ATE491468T1 (de) | 2011-01-15 |
AU2006304895B2 (en) | 2013-04-11 |
RS53723B1 (en) | 2015-06-30 |
CA2626452C (en) | 2018-09-04 |
JP2009511080A (ja) | 2009-03-19 |
US7468187B2 (en) | 2008-12-23 |
NO342145B1 (no) | 2018-04-03 |
DE602006018970D1 (de) | 2011-01-27 |
BRPI0617407A2 (pt) | 2011-07-26 |
HK1112846A1 (en) | 2008-09-19 |
NO20082149L (no) | 2008-07-16 |
EP1933866B1 (en) | 2010-12-15 |
KR20080046706A (ko) | 2008-05-27 |
EP1933866A2 (en) | 2008-06-25 |
US7842295B2 (en) | 2010-11-30 |
US20070098742A1 (en) | 2007-05-03 |
CA2626452A1 (en) | 2007-04-26 |
RU2008119438A (ru) | 2009-11-27 |
RU2410427C2 (ru) | 2011-01-27 |
US20090035325A1 (en) | 2009-02-05 |
AU2006304895A1 (en) | 2007-04-26 |
USRE44916E1 (en) | 2014-05-27 |
USRE45564E1 (en) | 2015-06-16 |
NZ567017A (en) | 2010-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR056133A1 (es) | Virus de influenza canina y composiciones relacionadas y metodos de uso | |
EA200801756A1 (ru) | Противогриппозные вакцины, содержащие гемагглютинин и белки матрикса | |
Sheahan et al. | Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus | |
AR059772A1 (es) | Composiciones que incuyen hemaglutinina metodos de elaboracion y metodos de uso de las mismas | |
TW200732476A (en) | Functional influenza virus like particles (VLPs) | |
AR082427A2 (es) | Sistemas de expresion de virus parainfluenza recombinantes y vacunas que comprenden antigenos heterologos derivados de metapneumovirus | |
ES2570758T3 (es) | Materiales y métodos para el control de enfermedades respiratorias en cánidos | |
NZ595736A (en) | Chimeric viruses presenting non-native surface proteins and uses thereof | |
ATE469972T1 (de) | Multiplasmid-system zur erzeugung des grippevirus | |
ATE460473T1 (de) | Immortalisierte entezelllinien zur viruserzeugung | |
EA200900784A1 (ru) | Вакцины, включающие антиген из четырех штаммов вируса гриппа | |
MX2011006846A (es) | Virus de fiebre porcina clasico recombinante (csfv) comprendiendo una proteina e2 modificada y metodos para generar dicho csfv. | |
BRPI0707779B8 (pt) | antígeno isolado, composição de vacina e método para produção de uma proteína antígeno | |
BRPI0519705A2 (pt) | composiÇÕes, proteÍnas de fusço e mÉtodos de estimular uma resposta imune em um indivÍduo | |
WO2005115448A8 (en) | Multi plasmid system for the production of influenza virus | |
JP2009511080A5 (es) | ||
CY1109036T1 (el) | Εμβολιο περιλαμβανον εναν εξασθενημενο ιο πανωλης | |
ME01140B (me) | Virus goveđe virusne dijareje s modifikovanim erns proteinom | |
AR094725A1 (es) | Parvovirus 5a porcino, métodos de uso y vacuna | |
DK1383795T3 (da) | Rekombinant nucleoproteinmutant fra Newcastle disease-virus som markörvaccine | |
MX2022012251A (es) | Vacuna universal contra la influenza usando arnm modificado con nucleósidos. | |
MX2023000041A (es) | Composiciones y metodos para inducir una respuesta inmunitaria contra coronavirus. | |
HRP20220980T1 (hr) | Cjepiva protiv virusa influence i njihova uporaba | |
AR057225A1 (es) | Vacunas marcadas contra el virus de la diarrea virica bovina | |
AR019250A1 (es) | Formas atenuadas del virus de la diarrea viral bovina, molecula de acido nucleico, vector, uso, metodo para modificar el genoma viral de tipo salvaje, genoma modificado, vacuna, metodo para atenuar un virus bvd de tipo salvaje |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |